Karyopharm reports positive phase 3 seal data in oral presentation at the connective tissue oncology society 2020 annual meeting

Newton, mass., nov. 20, 2020 /prnewswire/ -- karyopharm therapeutics inc. (nasdaq: kpti), a commercial-stage pharmaceutical company pioneering novel cancer therapies, today reported it will present positive results from the phase 3 portion of the randomized, double blind, placebo...
KPTI Ratings Summary
KPTI Quant Ranking